Production of an immunogenic trivalent poliovirus virus-like particle vaccine candidate in yeast using controlled fermentation.

Saved in:
Bibliographic Details
Title: Production of an immunogenic trivalent poliovirus virus-like particle vaccine candidate in yeast using controlled fermentation.
Authors: Sherry L; Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, LS2 9JT, UK. L.W.Sherry@leeds.ac.uk., Grehan K; Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, LS2 9JT, UK., Bahar MW; Division of Structural Biology, University of Oxford, The Henry Wellcome Building for Genomic Medicine, Headington, Oxford, OX3 7BN, UK., Swanson JJ; Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, LS2 9JT, UK., Fox H; Division of Vaccines, Medicines & Healthcare products Regulatory Agency (MHRA), Herts, EN6 3QG, UK., Matthews S; Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, LS2 9JT, UK., Carlyle S; Division of Vaccines, Medicines & Healthcare products Regulatory Agency (MHRA), Herts, EN6 3QG, UK., Qin L; Division of Structural Biology, University of Oxford, The Henry Wellcome Building for Genomic Medicine, Headington, Oxford, OX3 7BN, UK., Porta C; Division of Structural Biology, University of Oxford, The Henry Wellcome Building for Genomic Medicine, Headington, Oxford, OX3 7BN, UK., Wilkinson S; CPI, 1 Union Square, Central Park, Darlington, DL1 1GL, UK., Robb S; CPI, 1 Union Square, Central Park, Darlington, DL1 1GL, UK., Clark N; CPI, 1 Union Square, Central Park, Darlington, DL1 1GL, UK., Liddell J; CPI, 1 Union Square, Central Park, Darlington, DL1 1GL, UK., Fry EE; Division of Structural Biology, University of Oxford, The Henry Wellcome Building for Genomic Medicine, Headington, Oxford, OX3 7BN, UK., Stuart DI; Division of Structural Biology, University of Oxford, The Henry Wellcome Building for Genomic Medicine, Headington, Oxford, OX3 7BN, UK.; Diamond Light Source, Harwell Science and Innovation Campus, Didcot, OX11 0DE, UK.; Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford, OX3 7BN, UK., Macadam AJ; Division of Vaccines, Medicines & Healthcare products Regulatory Agency (MHRA), Herts, EN6 3QG, UK., Rowlands DJ; Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, LS2 9JT, UK. D.J.Rowlands@leeds.ac.uk., Stonehouse NJ; Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, LS2 9JT, UK. N.J.Stonehouse@leeds.ac.uk.
Source: NPJ vaccines [NPJ Vaccines] 2025 Mar 31; Vol. 10 (1), pp. 64. Date of Electronic Publication: 2025 Mar 31.
Publication Type: Journal Article
Journal Info: Publisher: Springer Nature in partnership with the Sealy Center for Vaccine Development Country of Publication: England NLM ID: 101699863 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-0105 (Electronic) Linking ISSN: 20590105 NLM ISO Abbreviation: NPJ Vaccines Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40164627
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Production of an immunogenic trivalent poliovirus virus-like particle vaccine candidate in yeast using controlled fermentation.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Sherry+L%22">Sherry L</searchLink>; Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, LS2 9JT, UK. L.W.Sherry@leeds.ac.uk.<br /><searchLink fieldCode="AU" term="%22Grehan+K%22">Grehan K</searchLink>; Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, LS2 9JT, UK.<br /><searchLink fieldCode="AU" term="%22Bahar+MW%22">Bahar MW</searchLink>; Division of Structural Biology, University of Oxford, The Henry Wellcome Building for Genomic Medicine, Headington, Oxford, OX3 7BN, UK.<br /><searchLink fieldCode="AU" term="%22Swanson+JJ%22">Swanson JJ</searchLink>; Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, LS2 9JT, UK.<br /><searchLink fieldCode="AU" term="%22Fox+H%22">Fox H</searchLink>; Division of Vaccines, Medicines & Healthcare products Regulatory Agency (MHRA), Herts, EN6 3QG, UK.<br /><searchLink fieldCode="AU" term="%22Matthews+S%22">Matthews S</searchLink>; Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, LS2 9JT, UK.<br /><searchLink fieldCode="AU" term="%22Carlyle+S%22">Carlyle S</searchLink>; Division of Vaccines, Medicines & Healthcare products Regulatory Agency (MHRA), Herts, EN6 3QG, UK.<br /><searchLink fieldCode="AU" term="%22Qin+L%22">Qin L</searchLink>; Division of Structural Biology, University of Oxford, The Henry Wellcome Building for Genomic Medicine, Headington, Oxford, OX3 7BN, UK.<br /><searchLink fieldCode="AU" term="%22Porta+C%22">Porta C</searchLink>; Division of Structural Biology, University of Oxford, The Henry Wellcome Building for Genomic Medicine, Headington, Oxford, OX3 7BN, UK.<br /><searchLink fieldCode="AU" term="%22Wilkinson+S%22">Wilkinson S</searchLink>; CPI, 1 Union Square, Central Park, Darlington, DL1 1GL, UK.<br /><searchLink fieldCode="AU" term="%22Robb+S%22">Robb S</searchLink>; CPI, 1 Union Square, Central Park, Darlington, DL1 1GL, UK.<br /><searchLink fieldCode="AU" term="%22Clark+N%22">Clark N</searchLink>; CPI, 1 Union Square, Central Park, Darlington, DL1 1GL, UK.<br /><searchLink fieldCode="AU" term="%22Liddell+J%22">Liddell J</searchLink>; CPI, 1 Union Square, Central Park, Darlington, DL1 1GL, UK.<br /><searchLink fieldCode="AU" term="%22Fry+EE%22">Fry EE</searchLink>; Division of Structural Biology, University of Oxford, The Henry Wellcome Building for Genomic Medicine, Headington, Oxford, OX3 7BN, UK.<br /><searchLink fieldCode="AU" term="%22Stuart+DI%22">Stuart DI</searchLink>; Division of Structural Biology, University of Oxford, The Henry Wellcome Building for Genomic Medicine, Headington, Oxford, OX3 7BN, UK.; Diamond Light Source, Harwell Science and Innovation Campus, Didcot, OX11 0DE, UK.; Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford, OX3 7BN, UK.<br /><searchLink fieldCode="AU" term="%22Macadam+AJ%22">Macadam AJ</searchLink>; Division of Vaccines, Medicines & Healthcare products Regulatory Agency (MHRA), Herts, EN6 3QG, UK.<br /><searchLink fieldCode="AU" term="%22Rowlands+DJ%22">Rowlands DJ</searchLink>; Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, LS2 9JT, UK. D.J.Rowlands@leeds.ac.uk.<br /><searchLink fieldCode="AU" term="%22Stonehouse+NJ%22">Stonehouse NJ</searchLink>; Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, LS2 9JT, UK. N.J.Stonehouse@leeds.ac.uk.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101699863%22">NPJ vaccines</searchLink> [NPJ Vaccines] 2025 Mar 31; Vol. 10 (1), pp. 64. <i>Date of Electronic Publication: </i>2025 Mar 31.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Nature+in+partnership+with+the+Sealy+Center+for+Vaccine+Development%22">Springer Nature in partnership with the Sealy Center for Vaccine Development </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101699863 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2059-0105 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220590105%22">20590105 </searchLink><i>NLM ISO Abbreviation: </i>NPJ Vaccines <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40164627
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41541-025-01111-2
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 64
    Titles:
      – TitleFull: Production of an immunogenic trivalent poliovirus virus-like particle vaccine candidate in yeast using controlled fermentation.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Sherry L
      – PersonEntity:
          Name:
            NameFull: Grehan K
      – PersonEntity:
          Name:
            NameFull: Bahar MW
      – PersonEntity:
          Name:
            NameFull: Swanson JJ
      – PersonEntity:
          Name:
            NameFull: Fox H
      – PersonEntity:
          Name:
            NameFull: Matthews S
      – PersonEntity:
          Name:
            NameFull: Carlyle S
      – PersonEntity:
          Name:
            NameFull: Qin L
      – PersonEntity:
          Name:
            NameFull: Porta C
      – PersonEntity:
          Name:
            NameFull: Wilkinson S
      – PersonEntity:
          Name:
            NameFull: Robb S
      – PersonEntity:
          Name:
            NameFull: Clark N
      – PersonEntity:
          Name:
            NameFull: Liddell J
      – PersonEntity:
          Name:
            NameFull: Fry EE
      – PersonEntity:
          Name:
            NameFull: Stuart DI
      – PersonEntity:
          Name:
            NameFull: Macadam AJ
      – PersonEntity:
          Name:
            NameFull: Rowlands DJ
      – PersonEntity:
          Name:
            NameFull: Stonehouse NJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 31
              M: 03
              Text: 2025 Mar 31
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2059-0105
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: NPJ vaccines
              Type: main
ResultId 1